The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1)

OBJECTIVE: To assess the impact of milrinone administration on time spent on nitric oxide (iNO) in infants with acute pulmonary hypertension (aPH). We hypothesized that intravenous milrinone used in conjunction with iNO would reduce the time on iNO therapy and the time spent on invasive ventilation...

Descripción completa

Detalles Bibliográficos
Autores principales: EL-Khuffash, Afif, McNamara, Patrick J., Breatnach, Colm, Bussmann, Neidin, Smith, Aisling, Feeney, Oliver, Tully, Elizabeth, Griffin, Joanna, de Boode, Willem P., Cleary, Brian, Franklin, Orla, Dempsey, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666925/
https://www.ncbi.nlm.nih.gov/pubmed/36385642
http://dx.doi.org/10.1038/s41372-022-01562-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666925/
https://www.ncbi.nlm.nih.gov/pubmed/36385642
http://dx.doi.org/10.1038/s41372-022-01562-8

Ejemplares similares